These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37306611)

  • 1. Pyroglutamate-modified amyloid β(3-42) monomer has more β-sheet content than the amyloid β(1-42) monomer.
    Nath S; Buell AK; Barz B
    Phys Chem Chem Phys; 2023 Jun; 25(24):16483-16491. PubMed ID: 37306611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy.
    Dammers C; Gremer L; Neudecker P; Demuth HU; Schwarten M; Willbold D
    PLoS One; 2015; 10(10):e0139710. PubMed ID: 26436664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Impact of N-terminal Pyroglutamate in an Amyloid-β(3-42) Fibril Probed by Solid-State NMR Spectroscopy.
    Gardon L; Becker N; Gremer L; Heise H
    Chemistry; 2024 Feb; 30(10):e202303007. PubMed ID: 38100216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Therapeutic d-Peptides with Aβ42 Monomers, Thermodynamics, and Binding Analysis.
    Leguizamon Herrera VL; Buell AK; Willbold D; Barz B
    ACS Chem Neurosci; 2022 Jun; 13(11):1638-1650. PubMed ID: 35580288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroglutamylation modulates electronic properties and the conformational ensemble of the amyloid β-peptide.
    Davidson DS; Lemkul JA
    Proteins; 2024 Jul; 92(7):842-853. PubMed ID: 38436541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights into the mitigation of Aβ aggregation and protofibril destabilization by a D-enantiomeric decapeptide rk10.
    Singh K; Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2022 Sep; 24(36):21975-21994. PubMed ID: 36069400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
    Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
    Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.
    Andarzi Gargari S; Barzegar A; Tarinejad A
    PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Seeded Fibrillation Induced by Pyroglutamate-3 and Truncated Aβ
    Hu ZW; Cruceta L; Zhang S; Sun Y; Qiang W
    ACS Chem Neurosci; 2021 Oct; 12(19):3625-3637. PubMed ID: 34524791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico and in vitro studies to elucidate the role of Cu2+ and galanthamine as the limiting step in the amyloid beta (1-42) fibrillation process.
    Hernández-Rodríguez M; Correa-Basurto J; Benitez-Cardoza CG; Resendiz-Albor AA; Rosales-Hernández MC
    Protein Sci; 2013 Oct; 22(10):1320-35. PubMed ID: 23904252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.
    Hook G; Yu J; Toneff T; Kindy M; Hook V
    J Alzheimers Dis; 2014; 41(1):129-49. PubMed ID: 24595198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characteristics of oligomers formed by pyroglutamate-modified amyloid β peptides studied by solid-state NMR.
    Scheidt HA; Das A; Korn A; Krueger M; Maiti S; Huster D
    Phys Chem Chem Phys; 2020 Jul; 22(29):16887-16895. PubMed ID: 32666970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal Binding of Alzheimer's Amyloid-β and Its Effect on Peptide Self-Assembly.
    Abelein A
    Acc Chem Res; 2023 Oct; 56(19):2653-2663. PubMed ID: 37733746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Analysis and Aggregation Propensity of Pyroglutamate Aβ(3-40) in Aqueous Trifluoroethanol.
    Dammers C; Gremer L; Reiß K; Klein AN; Neudecker P; Hartmann R; Sun N; Demuth HU; Schwarten M; Willbold D
    PLoS One; 2015; 10(11):e0143647. PubMed ID: 26600248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compact fibril-like structure of amyloid β-peptide (1-42) monomers.
    Barz B; Buell AK; Nath S
    Chem Commun (Camb); 2021 Jan; 57(7):947-950. PubMed ID: 33399148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
    Weiffert T; Meisl G; Flagmeier P; De S; Dunning CJR; Frohm B; Zetterberg H; Blennow K; Portelius E; Klenerman D; Dobson CM; Knowles TPJ; Linse S
    ACS Chem Neurosci; 2019 May; 10(5):2374-2384. PubMed ID: 30793584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival.
    Russo C; Violani E; Salis S; Venezia V; Dolcini V; Damonte G; Benatti U; D'Arrigo C; Patrone E; Carlo P; Schettini G
    J Neurochem; 2002 Sep; 82(6):1480-9. PubMed ID: 12354296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of the pyroglutamate-modified isoform of the Alzheimer's disease-related amyloid-β using NMR spectroscopy.
    Sun N; Hartmann R; Lecher J; Stoldt M; Funke SA; Gremer L; Ludwig HH; Demuth HU; Kleinschmidt M; Willbold D
    J Pept Sci; 2012 Nov; 18(11):691-5. PubMed ID: 23001756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.